Quick Takeaways
- SUSQUEHANNA SECURITIES, LLC filed SCHEDULE 13G for Purple Biotech Ltd. Ordinary Shares, no par value per share (PPBT).
- Disclosed ownership: 5.2%.
- Date of event: 31 Dec 2025.
SUSQUEHANNA SECURITIES, LLC - 31 Dec 2025 SCHEDULE 13G Report for Purple Biotech Ltd. Ordinary Shares, no par value per share (PPBT)
- Filing Manager
- SUSQUEHANNA SECURITIES, LLC
- Reporting Manager
- Susquehanna Securities, LLC
- Symbol
- PPBT
- Shares outstanding
- 1,806,796,154 shares
- Disclosed Ownership
- 93,953,400 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Feb 2026, 17:18:37 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SUSQUEHANNA SECURITIES, LLC disclosed 5.2% ownership in Purple Biotech Ltd. Ordinary Shares, no par value per share (PPBT) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2026, 17:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Susquehanna Securities, LLC | 5.2% | 93,953,400 | 93,953,400 | 93,953,400 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary |